Trial intelligence / Profile preview

Early Metoprolol in STEMI Patients with SCAI B Status

NCT06967194Recruiting

Sponsor
Tel Aviv Sourasky Medical Center
Start
May 2025
Primary completion
May 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in ST-elevation myocardial infarction (STEMI) comparing Metoprolol Arm with Placebo Arm (2 arms). Primary endpoint: Number of patients progressed from SCAI B to SCAI C at 3 days. Started May 2025; status: recruiting.

02

Drugs

metoprolol
03

Conditions

ST-elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT06967194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06967194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call